Impact of Perioperative Anesthetic Management on Renal Cancer Progression.
Withdrawn
- Conditions
- Renal CancerPerioperative Anesthetic
- Registration Number
- NCT06536244
- Lead Sponsor
- M.D. Anderson Cancer Center
- Brief Summary
The relationship between perioperative drugs, including preoperative medications, anesthetics, and analgesics, and postoperative outcomes in cancer patients is a complex and evolving field of study. Understanding how those medications might impact outcomes such as pain, acute kidney injury, and recurrence is crucial for optimizing perioperative care in renal cancer patients.
- Detailed Description
This retrospective study will investigate the association of perioperative drugs on short and long-term postoperative outcomes in patients undergoing kidney surgeries for renal cell carcinoma.
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- Adult Participants (18 years of age or older)
- Participants having radical or partial nephrectomies with curative intent.
Exclusion Criteria
- Patients with distant metastatic disease and those with multiple (more than 1) primary tumors at the time of the nephrectomy
- Biopsies
- Participants who had radiofrequency or microwave ablations.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Postoperative complications 72 hours and 30 days postoperatively
- Secondary Outcome Measures
Name Time Method Overall survival Recurrence-free survival:The length of time from surgery to last seen without recurrence or with recurrent disease. The length of time from surgery to last follow-up alive or death.
Trial Locations
- Locations (1)
MD Anderson Cancer Center
🇺🇸Houston, Texas, United States